An investor whose portfolio contains some value- or income-focused investments and some growth-oriented investments, who ...

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on June 19, 2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of ...

The bank's list of highest-conviction stock picks for 2026 spans numerous sectors and features names including Pepsi and GM.

After a weak first half, the drug and biotech sector regained momentum in the latter part of 2025, setting the stage for a ...

The U.K. government wants to boost the local life sciences industry, and it hopes to entice American venture capital firms to ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

Learn more about whether Legend Biotech Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's ...

BRISTOL, TN, TN / ACCESS Newswire / October 14, 2025 / For decades, biotechnology investing was a binary game - a single trial failure could erase years of progress and billions in shareholder value.